A Phase 1 study to determine maximum tolerated dose of sublingual fentanyl in combination with oral oxycodone for hospital management of an acute painful crisis in adolescents and adults with sickle cell disease

Authors
Publication date
1 March 2019
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Supporting member

    Queen Mary Research Online

    redirect
    oaioai:qmro.qmul.ac.uk:123456789/...
    Last time updated on 04/09/2020